AEON Biopharma, Inc. (AEON) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.63M | 3.4M | 7.41M | 10.26M | 12.32M | 1.59M | 2.37M | 4.02M | 2.5M | 6.22M | 9.84M |
| Cash & Short-Term Investments | 6.24M | 3.01M | 5.93M | 8.44M | 10.45M | 13K | 537K | 3.44M | 1.56M | 5.16M | 9.75M |
| Cash Only | 6.24M | 3.01M | 5.93M | 8.44M | 10.45M | 13K | 537K | 3.44M | 1.56M | 5.16M | 9.75M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 382K | 392K | 0 | 1.82M | 1.88M | 1.58M | 1.83M | 577K | 940K | 0 | 92K |
| Total Non-Current Assets | 2M | 2.16M | 1.32M | 1.4M | 1.48M | 1.55M | 1.63M | 1.72M | 534K | 623K | 940K |
| Property, Plant & Equipment | 1.13M | 1.21M | 1.29M | 1.37M | 1.45M | 1.52M | 1.6M | 1.69M | 505K | 594K | 906K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.71M | 0 |
| Other Non-Current Assets | 871K | 948K | 29K | 29K | 29K | 29K | 29K | 29K | 29K | -60.68M | 34K |
| Total Assets | 8.63M | 5.56M | 8.73M | 11.66M | 13.8M | 3.14M | 4M | 5.73M | 3.03M | 6.84M | 10.78M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -37.46% | 76.96% | 118.13% | 103.38% | 355.11% | -54.1% | - | - | - | -36.49% | - |
| Total Current Liabilities | 6.67M | 6.9M | 8.23M | 9.13M | 8.64M | 14.15M | 10.73M | 10.43M | 15.96M | 13.05M | 82.57M |
| Accounts Payable | 1.48M | 942K | 2.52M | 3.91M | 2.44M | 5.91M | 4.63M | 3.03M | 6.52M | 3.39M | 7.8M |
| Days Payables Outstanding | 5.74K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 258K | 0 | 247K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70.87M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.23M | 0 | 0 |
| Other Current Liabilities | 3.1M | 2.87M | -247K | 546K | 429K | 1.07M | 1.56M | 1.25M | -1.89M | 0 | 1.11M |
| Current Ratio | 0.99x | 0.49x | 0.90x | 1.12x | 1.43x | 0.11x | 0.22x | 0.39x | 0.16x | 0.48x | 0.12x |
| Quick Ratio | 0.99x | 0.49x | 0.90x | 1.12x | 1.43x | 0.11x | 0.22x | 0.39x | 0.16x | 0.48x | 0.12x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 18.71M | 53.69M | 20.38M | 18.39M | 16.48M | 17.56M | 25.37M | 23.25M | 185.46M | 146.84M | 198.62M |
| Long-Term Debt | 1.54M | 34.6M | 17.05M | 15.17M | 13.32M | 11.69M | 15.17M | 13.29M | 5.09M | 0 | 60.43M |
| Capital Lease Obligations | 825K | 893K | 957K | 1.02M | 1.08M | 1.15M | 1.2M | 1.26M | 0 | 0 | 242K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 16.35M | 18.2M | 2.37M | 2.19M | 2.08M | 4.73M | 8.99M | 8.7M | 180.37M | 146.84M | 137.95M |
| Total Liabilities | 25.38M | 60.59M | 28.61M | 27.51M | 25.12M | 31.71M | 36.09M | 33.68M | 201.41M | 159.89M | 281.19M |
| Total Debt | 2.63M | 35.74M | 18.25M | 16.44M | 14.6M | 12.96M | 16.5M | 14.69M | 5.29M | 278K | 131.53M |
| Net Debt | -3.62M | 32.74M | 12.33M | 8M | 4.15M | 12.94M | 15.96M | 11.25M | 3.73M | -4.88M | 121.79M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.10x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | 0.07x | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -16.75M | -55.03M | -19.87M | -15.85M | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M | -153.04M | -270.41M |
| Equity Growth % | -47.95% | -92.61% | 38.07% | 43.28% | 94.29% | 81.33% | - | - | - | 43.4% | - |
| Book Value per Share | -1.38 | -4.55 | -1.71 | -1.43 | -2.84 | -51.44 | -58.47 | -51.77 | -383.04 | -296.54 | -140.22 |
| Total Shareholders' Equity | -16.75M | -55.03M | -19.87M | -15.85M | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M | -153.04M | -287.5M |
| Common Stock | 10K | 9K | 9K | 9K | 9K | 4K | 4K | 4K | 4K | 4K | 14K |
| Retained Earnings | -482.61M | -470.82M | -433.68M | -429.14M | -422.5M | -431.6M | -433.68M | -427.51M | -591.62M | -473.6M | -474.84M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60.71M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.09M |